Document is current
Any future updates will be listed below
-
Authors
Sledge, George W. Jr.
Yoshino, Takayuki https://orcid.org/0000-0002-0489-4756
Xiu, Joanne
Helmstetter, Anthony
Ribeiro, Jennifer R. https://orcid.org/0000-0002-1685-8568
Klimov, Sergey
Gilg, Brady
Gao, JJ
Elton, Jeff https://orcid.org/0009-0006-9877-3387
Oberley, Matthew J. https://orcid.org/0000-0001-6419-2513
Radovich, Milan
Abraham, Jim
Spetzler, David https://orcid.org/0000-0002-9531-0970
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 28 February 2025
First Online: 18 March 2025
Competing interests
: G.W.S., T.Y., J.X., A.H., J.R.R., S.K., B.G., J.J.G., M.J.O., M.R., J.A., and D.S. are employees of Caris Life Sciences. J.E. is CEO of ConcertAI. T.Y. reports honoraria from Chugai Pharmaceutical, Takeda Pharmaceutical, Merck Biopharma, Bayer Yakuhin, Ono Pharmaceutical and MSD K.K.; consulting fee from Sumitomo Corp.; and research grant from Amgen, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo. Eisai, FALCO biosystems, Genomedia, Medical & Biological Laboratories, Merus N.V., Molecular Health GmbH, MSD, Nippon Boehringer Ingelheim, Ono Pharmaceutical, Pfizer Japan, Roche Diagnostics, Sanofi, Sysmex, Taiho Pharmaceutical and Takeda Pharmaceutical.
